What is Biostage, Inc. (BSTG)?

Biostage, Inc. (BSTG) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of BSTG?

The current price of BSTG is $4.03. Prices are updated in real time on Stocks360.

What is BSTG's price-to-earnings (PE) ratio?

BSTG's trailing twelve-month PE ratio is -10.08, based on current price and earnings per share data available on Stocks360.

What is BSTG's market capitalization?

BSTG's market capitalization is $57,824,048.00, placing it in the small-cap tier.

Biostage, Inc. (BSTG)

Stock analysis · OTC · Healthcare · Biotechnology

$4.03

Market Cap

$57.82M

PE (TTM)

-10.08

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.97

Day Range

$4.00 – $4.14

52-wk Range

$3.65 – $9.00

Avg Volume

N/A

Volume

4.53K

Biostage, Inc. (BSTG) is a publicly traded company in the Healthcare sector. Latest price: $4.03. Market cap $57.82M. Trailing PE -10.08. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 14, 2017

EPS $-2.00 vs est. $-0.07

Missed by $1.93

Proprietary Signals

Signal snapshot temporarily unavailable.

About Biostage, Inc.

Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-10.08×
P/S (TTM)	0.00×
P/B	-51.38×
PEG	6.85×
P/FCF (TTM)	-15.91×
EV / EBITDA	30.14×
EV / Sales	0.00×
Earnings Yield	-9.43%
Free Cash Flow Yield	-6.29%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$58.12M
Net Income (TTM)	-$5.45M
Free Cash Flow (TTM)	-$3.64M
Net Debt	$294.00K
Working Capital	-$2.25M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-2019.03%
Return on Invested Capital	1047.96%